#$%^&*AU2012203914A120120726.pdf#####C:\NRPorbP\DCCRXSW443998_ I. DOC.3A)7/2012 ABSTRACT The invention relates to the use of compounds of formula (1) or (11) in the treatment of mammalian target of VEGF-driven angiogenic diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases. The invention relates to the use of compounds of formula (1) or (11) in the treatment of mammalian target of VEGF-driven angiogenic diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases. H2N W R3 NN R1 R4 NN N 4 NN N R6 R7 (()N ()) (RO)n
